How in The halibut is this going to sub .01 with positive 12 month data and partnerships worldwide and cash flow finally coming in?

Bioheart announces positive 12 month data

http://finance.yahoo.com/news/bioheart-announces-positive-12-month-120000542.html?.tsrc=applewf

Better news would be financing to complete SDF and results from Adipose

Scientist honoured by the Vatican on verge of stem-cell breakthrough http://flip.it/JFIJN

How is Bhrt compared to Meso?

Mayo Clinic First in U.S. Testing Stem Cell Use in Pediatric Congenital Heart Disease Trial http://flip.it/udVh1

Australian scientists accidentally make one of the most significant discoveries in stem cell research http://flip.it/rOxMK

Heart Makers
http://flip.it/ceknm

We are due soon on Angel 12 month a a blog from Mr. Thomas.

What we like to see, reduction of debt and increased revenue

English please....help me out is he buying or selling

Not comparing, just hoping we get a product to market soon.

http://seekingalpha.com/currents/post/1858505?source=iphoneportfolioapp_message

One day...one day

http://bit.ly/1sokLVO

Dilution!!!!!!!!!!!!

Bioheart converts debt
06:32 PM ET · BHRT

As part its restructuring to improve its chances of securing additional financing, Bioheart (BHRT -6.7%) settles a debt of $1,508,219.19 by issuing 37,705,478 shares of common stock. The transaction represents a 7.6% dilution for current shareholders.
The current holders of the company's Series A Convertible Preferred Stock have agreed to exchange their shares for shares of common stock contingent upon the company securing financing.

http://finance.yahoo.com/news/bioheart-announces-joint-venture-south-120000344.html?.tsrc=applewf

Transparency for investors.... Really those words do not go together .

So many studies no product to market.

Can ‘Young Blood’ Reverse Aging in Humans?

http://flip.it/AoCCq

So many different trials there into, yet they are burning through cash like there's no tomorrow. Concentrate on your strongest and get it to market .

Stem Cells May Rejuvenate Failing Hearts, Study Suggests
http://www.drugs.com/news/stem-cells-may-rejuvenate-failing-hearts-study-suggests-50994.html?utm_keyword=ZootRock

Doesnt seem bhrt Is the leader in this space


Stem Cells May Rejuvenate Failing Hearts, Study Suggests
http://www.drugs.com/news/stem-cells-may-rejuvenate-failing-hearts-study-suggests-50994.html?utm_keyword=ZootRock

"MIRROR studies is dependent on obtaining the necessary funding" Sounds like Mirror has a ways to go and does not have the enrollment nor the funding? Thoughts?

From Mike today:

"Thanks, C. Look for a CSO blog in the next few days to help with your trial questions. Warm regards.

Mike"

Sorry, that link was from Yahoo, here is the full 10K

http://archive.fast-edgar.com//20140325/AQKXK22CZ222B2Z2222G2WZ4LDAIZD223262/

No mention of how the Phase 3 is going and no revenues expected until approval of phase 3, and not before 2015.

"We do not expect to generate substantial revenues until we obtain regulatory approval for and commercialize our product candidates, which we do not expect to occur before 2015."

10K is out, doesnt look good.

10K has been filed

http://biz.yahoo.com/e/140325/bhrt10-k.html

My question is, how does Meso become so big and Bio so far behind when their product is so far ahead of Meso ?

Wouldn't you think 126 would have been enrolled by now?

My bad, not trying to mislead anyone. Simply misinterpreted the info, thanks for pointing it out.

Look under the heading on the website

"SEC Transaction Summary - last 6 Months"

You will see the three buys at 17,346,490 and 0 sold.

In fact in the last 6 months insiders have accumulated over 17 million shares.

What call was made? I see this heading to below .02 then backup when the Myocell news hits.

I'm in for the long haul. But I like to take some profits and buy the dips. The charts speak load and clear.

Sell???? Time to sell was at the peak of .06 - .08. I called the plummet days ago, waiting for resistance before loading up again on some of the profits I took at the peak.

However pages 18 and 19, demonstrates current drugs and companies in the cardiovascular pipeline and rates Mesoblast the highest and does not even mention Bioheart in the top 15 list shown.

That's why I took profits at the peak, getting back in after it bottoms to the resistance

Where would the pullback land if It went to .1? Where would the next entry be

A pullback will happen before the 31st 10k unless Mike comes out with a blog prior too the 10k